Global Contrast Media Market
- MAR2978595
- 221 Pages
- March 2018
- Pharmaceuticals
End-user/Technology
Healthcare centers and hospitals are the main users of this technology. Two of the most common contrast media method used in the market are X-ray attenuation and MR signal enhancing. Generally, Iodine and Barium are being used for X-ray based imaging technique. Further Iodine can be subdivided based on the viscosity, osmolarity, and absolute Iodine content. Gadolinium is used for magnetic resonance signal enhancement. Ultrasound scattering and frequency shift is the technology where microbubble contrast agents are used for sonographic examination such as the echocardiogram.
Market Dynamics
Advancement in imaging technology, rising chronic diseases (i.e. cardiac, cancer etc.), the aging population, increasing research and development activities are the main driving force for the growth of the contrast media market. On the other hand lack of awareness among people, insufficiently trained professionals, high cost, and stringent Govt. regulations are some of the primary restraints. X-ray attenuation technique has the largest market share and expected to have a high growth rate in the forecasted period. Also, it is expected that ultrasonic method will experience a substantial growth in the period of consideration.
Market Segments
The contrast media market can be segmented based on the product as well as procedure. Based on the products it can be subdivided into 3 groups which include Gadolinium contrast media, Barium contrast media, and Iodine contrast media. Based on the procedure three of the most common techniques used are X-ray attenuation, MR signal enhancing and ultrasound scattering. This technology has vast application in detecting nephrological disorder, cardiovascular disorder, and gastrointestinal disorder.
Regional/Geographic Analysis
North America is the market leader followed by Europe and Asia Pacific. Technological advancement, venture capital investment, govt support and increasing demand ensure North America's leadership in the contrast media market. High purchasing power and disposable income in North America and Europe also ensure the market growth. Investors and manufacturers are highly interested in Asia Pacific regions due to the presence of untapped market with lots of opportunities. Other geographic markets include South America, Japan, and Middle East & Africa.
Opportunities
Technological advancement, Govt. support and increasing awareness among people are creating lots of opportunities in the current market. Research is going on to remove the complication arising from the interaction of contrast media with the human body. The highest growth rate is expected to be in the Asia Pacific region in the forecasted period. Various R&D work in critical disease sector and complex surgical procedures are also creating opportunities for the market to grow.
Key Players
Some of the major players in the market include Bayer Healthcare Pharmaceuticals (Germany), Medrad Inc., Lantheus Medical, SupertechInc, AMAG Pharmaceuticals, Inc, ACIST Medical Systems Canadian Imaging, TargesonInc, Pinyons Medical Technology, Mallinckrodt Pharmaceuticals, Daiichi, Nova Biomedical, Covidien (Ireland), Bracco Diagnostic Inc. (Italy), GE Healthcare (U.K.), and Guerbet Group (France).
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
1.1. Market Definition
1.2. Market Taxonomy
2. Research Methodology
3. Assumptions and Acronyms
4. Executive Summary
5. Consumer Analysis
5.1. Consumer Profile (Demographic, Geographic, etc.)
5.2. Consumer Motivation
5.3. Procurement Process
5.4. Frequency of Buying
6. Historical Overview (Market Origins, Product Launch
Timeline, etc.)
7. Pricing Analysis
8. Market Dynamics
8.1. Macroeconomic Factors
8.2. Drivers
8.2.1.Supply Side
8.2.2.Demand Side
8.3. Restraints
8.4. Opportunities
9. R&D Status and Technology Overview
10. Global Contrast Media Market Analysis, By Product Type
10.1. Introduction
10.2. Prominent Trends
10.3. Regulatory Guidelines
10.4. Market Size and Analysis, By Product Type
10.4.1. Radio Contrast Agents (X Ray/CT Contrast Media)
10.4.1.1. Barium Sulfate Contrast Media
10.4.1.2. Iodinated Contrast Media
10.4.1.2.1. High-osmolar Contrast Media (HOCM)
10.4.1.2.2. Low-osmolar Contrast Media (HOCM)
10.4.1.2.3. Iso-osmolar Contrast Media (HOCM)
10.4.1.3. Others
10.4.2. MRI Contrast Agents
10.4.2.1. Gadolinium-based Agents
10.4.2.2. Others
10.4.3.Ultrasound Agents
10.4.3.1. Microbubbles and Microspheres
10.4.4.Others
10.5. Market Share Analysis and YoY Growth Rates, By Product
Type
11. Global Contrast Media Market Analysis, By Product Form
11.1. Introduction
11.2. Prominent Trends
11.3. Market Size and Analysis, By Product Form
11.3.1. Injection
11.3.2. Oral Suspension
11.3.3. Paste
11.3.4. Tablets
11.3.5. Others
11.4. Market Share Analysis and YoY Growth Rates, By Product
Form
12. Global Contrast Media Market Analysis, By Region
12.1. Introduction
12.2. Prominent Trends
12.3. Market Size and Analysis, By Region
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East & Africa (MEA)
12.4. Market Share Analysis and YoY Growth Rates, By Region
13. North America Contrast Media Market Analysis
13.1. Introduction
13.2. Prominent Trends
13.3. North America Contrast Media Market Analysis, by
Country
13.3.1. U.S.
13.3.2. Canada
13.4. North America Contrast Media Market Analysis, By
Product Type
13.4.1. Radio Contrast Agents (X Ray/CT Contrast Media)
13.4.1.1. Barium Sulfate Contrast Media
13.4.1.2. Iodinated Contrast Media
13.4.1.2.1. High-osmolar Contrast Media (HOCM)
13.4.1.2.2. Low-osmolar Contrast Media (HOCM)
13.4.1.2.3. Iso-osmolar Contrast Media (HOCM)
13.4.1.3. Others
13.4.2. MRI Contrast Agents
13.4.2.1. Gadolinium-based Agents
13.4.2.2. Others
13.4.3.Ultrasound Agents
13.4.3.1. Microbubbles and Microspheres
13.4.4.Others
13.5.North America Contrast Media Market Size and Analysis,
By Product Form
13.5.1. Injection
13.5.2. Oral Suspension
13.5.3. Paste
13.5.4. Tablets
13.5.5. Others
13.6. North America Contrast Media Market Share Analysis
and YoY Growth Rates
13.6.1. By Country
13.6.2. By Product Form
13.6.3. By Product Type
14. Latin America Contrast Media Market Analysis
14.1. Introduction
14.2. Prominent Trends
14.3. Latin America Contrast Media Market Analysis, by
Country
14.3.1. Mexico
14.3.2. Brazil
14.3.3. Others
14.4. Latin America Contrast Media Market Analysis, By
Product Type
14.4.1. Radio Contrast Agents (X Ray/CT Contrast Media)
14.4.1.1. Barium Sulfate Contrast Media
14.4.1.2. Iodinated Contrast Media
14.4.1.2.1. High-osmolar Contrast Media (HOCM)
14.4.1.2.2. Low-osmolar Contrast Media (HOCM)
14.4.1.2.3. Iso-osmolar Contrast Media (HOCM)
14.4.1.3. Others
14.4.2. MRI Contrast Agents
14.4.2.1. Gadolinium-based Agents
14.4.2.2. Others
14.4.3.Ultrasound Agents
14.4.3.1. Microbubbles and Microspheres
14.4.4.Others
14.5.Latin America Contrast Media Market Size and Analysis,
By Product Form
14.5.1. Injection
14.5.2. Oral Suspension
14.5.3. Paste
14.5.4. Tablets
14.5.5. Others
14.6. Latin America Contrast Media Market Share Analysis and
YoY Growth Rates
14.6.1. By Country
14.6.2. By Product Form
14.6.3. By Product Type
15. Europe Contrast Media Market Analysis
15.1. Introduction
15.2. Prominent Trends
15.3. Europe Contrast Media Market Analysis, by Country
15.3.1. Germany
15.3.2. U.K.
15.3.3. Spain
15.3.4. France
15.3.5. Italy
15.3.6. Russia
15.3.7. Others
15.4. Europe Contrast Media Market Analysis, By Product Type
15.4.1. Radio Contrast Agents (X Ray/CT Contrast Media)
15.4.1.1. Barium Sulfate Contrast Media
15.4.1.2. Iodinated Contrast Media
15.4.1.2.1. High-osmolar Contrast Media (HOCM)
15.4.1.2.2. Low-osmolar Contrast Media (HOCM)
15.4.1.2.3. Iso-osmolar Contrast Media (HOCM)
15.4.1.3. Others
15.4.2. MRI Contrast Agents
15.4.2.1. Gadolinium-based Agents
15.4.2.2. Others
15.4.3.Ultrasound Agents
15.4.3.1. Microbubbles and Microspheres
15.4.4.Others
15.5.Europe Contrast Media Market Size and Analysis, By
Product Form
15.5.1. Injection
15.5.2. Oral Suspension
15.5.3. Paste
15.5.4. Tablets
15.5.5. Others
15.6. Europe Contrast Media Market Share Analysis and YoY
Growth Rates
15.6.1. By Country
15.6.2. By Product Form
15.6.3. By Product Type
16. Asia Pacific Contrast Media Market Analysis
16.1. Introduction
16.2. Prominent Trends
16.3. Asia Pacific Contrast Media Market Analysis, by Country
16.3.1. India
16.3.2. China
16.3.3. Australia & New Zealand
16.3.4. Japan
16.3.5. Others
16.4. Asia Pacific Contrast Media Market Analysis, By Product
Type
16.4.1. Radio Contrast Agents (X Ray/CT Contrast Media)
16.4.1.1. Barium Sulfate Contrast Media
16.4.1.2. Iodinated Contrast Media
16.4.1.2.1. High-osmolar Contrast Media (HOCM)
16.4.1.2.2. Low-osmolar Contrast Media (HOCM)
16.4.1.2.3. Iso-osmolar Contrast Media (HOCM)
16.4.1.3. Others
16.4.2. MRI Contrast Agents
16.4.2.1. Gadolinium-based Agents
16.4.2.2. Others
16.4.3.Ultrasound Agents
16.4.3.1. Microbubbles and Microspheres
16.4.4.Others
16.5.Asia Pacific Contrast Media Market Size and Analysis, By
Product Form
16.5.1. Injection
16.5.2. Oral Suspension
16.5.3. Paste
16.5.4. Tablets
16.5.5. Others
16.6. Asia Pacific Contrast Media Market Share Analysis and
YoY Growth Rates
16.6.1. By Country
16.6.2. By Product Form
16.6.3. By Product Type
17. Middle East and Africa (MEA) Contrast Media Market Analysis
17.1. Introduction
17.2. Prominent Trends
17.3. Middle East and Africa Contrast Media Market Analysis,
by Country
17.3.1. GCC countries
17.3.2. South Africa
17.3.3. North Africa
17.3.4. Rest of Middle East and Africa
17.4. MEA Contrast Media Market Analysis, By Product Type
17.4.1. Radio Contrast Agents (X Ray/CT Contrast Media)
17.4.1.1. Barium Sulfate Contrast Media
17.4.1.2. Iodinated Contrast Media
17.4.1.2.1. High-osmolar Contrast Media (HOCM)
17.4.1.2.2. Low-osmolar Contrast Media (HOCM)
17.4.1.2.3. Iso-osmolar Contrast Media (HOCM)
17.4.1.3. Others
17.4.2. MRI Contrast Agents
17.4.2.1. Gadolinium-based Agents
17.4.2.2. Others
17.4.3.Ultrasound Agents
17.4.3.1. Microbubbles and Microspheres
17.4.4.Others
17.5.MEA Contrast Media Market Size and Analysis, By Product
Form
17.5.1. Injection
17.5.2. Oral Suspension
17.5.3. Paste
17.5.4. Tablets
17.5.5. Others
17.6. MEA Contrast Media Market Share Analysis and YoY
Growth Rates
17.6.1. By Country
17.6.2. By Product Form
17.6.3. By Product Type
18. Industry Structure
18.1. Porters Five Forces Analysis
18.1.1. Bargaining Power of Suppliers
18.1.2. Bargaining Power of Buyers
18.1.3. Threat of New Entrants
18.1.4. Threat of Substitute Products and Services
18.1.5. Internal Rivalry
18.2.Supply Chain Analysis and Profitability Margins
18.3.Market Share Analysis
18.4. Strategic Analysis
18.4.1. Competitive Strategies
18.4.2. Mergers & Acquisitions Activity
18.4.3. Co-operative Agreements
18.5. Critical Success Factor (CSF) Analysis (Technology &
Manufacturing, Design & Features, Brand Reputation,
Distribution Network, Marketing)
18.6.Company Profiles (Overview, Product/Service Details,
Geographic Scope, Financials, Strategic Intent & Approach,
Core Competencies & Competitive Advantage and Key
developments)
18.6.1. GE Healthcare
18.6.2. Guerbet
18.6.3. Bracco Diagnostics
18.6.4. Bayer HealthCare Pharmaceuticals
18.6.5. Covidien
18.6.6. Siemens Healthineers
18.6.7. Philips Healthcare
18.6.8. Fujifilm
18.6.9. Agfa Healthcare Corporation
18.6.10. Lantheus Holdings
18.6.11. Daiichi Sankyo
18.6.12. Others
19. Prognosis for the Future
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
